New Alzheimer’s Drug Raises Hopes — Along With Questions
(By Judith Graham for KFF Health News) The FDA has approved Leqembi, the first disease-modifying treatment for early-stage Alzheimer’s and
Read More(By Judith Graham for KFF Health News) The FDA has approved Leqembi, the first disease-modifying treatment for early-stage Alzheimer’s and
Read More(Source – va.news.gov) With nearly half of Veterans over the age of 65, VA’s Office of Geriatrics and Extended Care
Read More(By Judith Graham for KFF Health News) Corlee Morris has dieted throughout her adult life. After her weight began climbing
Read More(By Ambar Castillo for STAT) Americans who live in neighborhoods with less socioeconomic advantage may have a higher risk of
Read More(By Judith Graham for KFF Health News) Millions of people enter later life carrying an extra 10 to 15 pounds,
Read More(By Rylee Wilson for Becker’s Hospital Review) Leqembi, the newly-approved drug that can slow the progression of Alzhemier’s disease, will
Read More(By Arthur Allen for KFF Health News) This week the FDA is expected to approve what many scientists and doctors
Read MoreBy Sara Boden, WESA on June 20, 2023 for Kaiser Family Foundation Angela Reynolds knew her mother’s memory was slipping,
Read MoreBy Jon Hamilton on June 19, 2023 for NPR Diseases like Alzheimer’s, Parkinson’s, and Huntington’s are caused by toxic clumps
Read More(By Sarah Boden for NPR) Sharon Gwinn had been married almost 30 years when she cleared out the savings and
Read More